MARKET

ISR

ISR

Isoray
AMEX
0.4010
+0.0010
+0.25%
After Hours: 0.4020 +0.001 +0.25% 19:48 02/03 EST
OPEN
0.3900
PREV CLOSE
0.4000
HIGH
0.4091
LOW
0.3900
VOLUME
327.29K
TURNOVER
0
52 WEEK HIGH
0.4499
52 WEEK LOW
0.1922
MARKET CAP
56.99M
P/E (TTM)
-6.2656
1D
5D
1M
3M
1Y
5Y
BRIEF-Isoray Announces Adjournment Of Annual Meeting Of Stockholders To Jan. 27
Reuters · 01/12 22:59
Organigram And Rounding Out My Tax Loss Selling Basket
Seeking Alpha · 01/02 12:07
AMENDED: Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2023
RICHLAND, Wash., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that the December 13th, 2022, A...
GlobeNewswire · 12/14/2022 22:08
Vapotherm, Redwire And These 2 Penny Stocks Insiders Are Aggressively Buying
Benzinga · 12/06/2022 11:28
BRIEF-Isoray Inc Has Entered Into Promissory Note And Security Agreement With Viewpoint Molecular Targeting
Reuters · 11/29/2022 22:01
'Isoray And Manufacturing Partner GT Medical Technologies Have Received FDA 510k Clearance For GammaTile, Likely For A New Indication' - FDA
Benzinga · 11/14/2022 20:38
BRIEF-Isoray Inc Reports Q1 Loss Per Share Of $0.03
Reuters · 11/10/2022 21:21
IsoRay GAAP EPS of -$0.03 misses by $0.02, revenue of $1.72M misses by $1.41M
Seekingalpha · 11/10/2022 21:06
More
About ISR
Isoray, Inc. is a medical technology company. The Company, through its subsidiary, Isoray Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in production and sale of Cesium-131 brachytherapy seeds. Brachytherapy seeds are small devices that deliver a personalized targeted therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor. The Cesium-131 includes radioisotope in the treatment of all malignant tumors, such as prostate cancer, brain cancer, colorectal cancer, gynecological cancer, lung cancer, ocular melanoma and pancreatic cancer. The Company’s Cesium-131 is classified as a Class II device.

Webull offers kinds of Isoray Inc stock information, including AMEX:ISR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ISR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ISR stock methods without spending real money on the virtual paper trading platform.